{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:07:23Z","timestamp":1760659643801,"version":"build-2065373602"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Polymorphisms in the XRCC3 gene, a key component of homologous recombination repair, have been studied for their potential role in thyroid cancer susceptibility. However, published findings remain inconsistent across populations and genetic variants. This meta-analysis aimed to clarify the associations between XRCC3 polymorphisms and thyroid cancer risk, with emphasis on variant- and ethnicity-specific effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A systematic search of PubMed, EMBASE, Scopus, CNKI, and other databases up to July 10, 2025 identified case\u2013control studies reporting genotype distributions of XRCC3 polymorphisms in thyroid cancer. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated under fixed- or random-effects models. Subgroup analyses by ethnicity, sensitivity tests, and publication bias assessments (Egger\u2019s and Begg\u2019s tests) were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-four eligible studies were included: 14 for rs861539, six for rs1799796, and four for rs1799794, comprising 4,502 cases and 6,048 controls. For rs861539, no significant association with thyroid cancer risk was observed in the overall population (T vs. C: OR\u2009=\u20091.089, 95% CI\u2009=\u20090.908\u20131.306, <jats:italic>p<\/jats:italic>\u2009=\u20090.358), with consistent null results across Asian and Caucasian subgroups. For rs1799796, no overall association was detected (G vs. A: OR\u2009=\u20090.970, 95% CI\u2009=\u20090.875\u20131.075, <jats:italic>p<\/jats:italic>\u2009=\u20090.558), but a protective effect emerged in Asian populations (GA vs. AA: OR\u2009=\u20090.835, 95% CI\u2009=\u20090.701\u20130.995, <jats:italic>p<\/jats:italic>\u2009=\u20090.043). For rs1799794, significant associations were found under recessive models (GG vs. AA: OR\u2009=\u20091.371, 95% CI\u2009=\u20091.066\u20131.762, <jats:italic>p<\/jats:italic>\u2009=\u20090.014; GG vs. GA\u2009+\u2009AA: OR\u2009=\u20091.316, 95% CI\u2009=\u20091.037\u20131.669, <jats:italic>p<\/jats:italic>\u2009=\u20090.024). Considerable heterogeneity was observed (I\u00b2 = 42.2\u201393.3%), and eight studies deviated from Hardy\u2013Weinberg equilibrium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>XRCC3 rs1799794 polymorphism is associated with increased thyroid cancer risk, particularly under recessive genetic models. The rs1799796 variant may confer a protective effect in Asian populations, whereas rs861539 shows no significant association. These results highlight population-specific genetic effects and underscore the importance of considering ethnicity in genetic association studies. Further large, well-designed investigations are warranted to confirm these findings and to explore potential gene\u2013environment interactions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12902-025-02044-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:43:09Z","timestamp":1760578989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive compilation of data on the association between XRCC3 polymorphisms and thyroid cancer susceptibility"],"prefix":"10.1186","volume":"25","author":[{"given":"Mahdi","family":"Khosravi-Mashzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Masoud","family":"HaghighiKian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhosein","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Negahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Vakili-Ojarood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahareh","family":"Mehdikhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezvan","family":"Nezameslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Nezameslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amihossein","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirmasoud","family":"Shiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Neamatzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2044_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2044_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1503144","volume":"16","author":"MJ Jia","year":"2025","unstructured":"Jia MJ, Wang S, Li Y, Liu XN, Jiang F, Li HL. Global burden of thyroid cancer among adolescents and young adults, 1990\u20132021, and projections to 2050: an analysis based on the GBD 2021. Front Endocrinol (Lausanne). 2025;16:1503144.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2044_CR3","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1097\/CM9.0000000000003284","volume":"137","author":"Z Lyu","year":"2024","unstructured":"Lyu Z, Zhang Y, Sheng C, Huang Y, Zhang Q, Chen K. Global burden of thyroid cancer in 2022: incidence and mortality estimates from GLOBOCAN. Chin Med J (Engl). 2024;137:2567.","journal-title":"Chin Med J (Engl)"},{"key":"2044_CR4","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"2044_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000983","author":"M Fu","year":"2025","unstructured":"Fu M, Peng Z, Wu M. Thyroid cancer in Asia: incidence, mortality in 2022, and future projections to 2050. Eur J Cancer Prev. 2025. https:\/\/doi.org\/10.1097\/CEJ.0000000000000983.","journal-title":"Eur J Cancer Prev"},{"key":"2044_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB. Cancer progress and priorities: epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev. 2022;31:1284.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2044_CR7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.31557\/APJCP.2021.22.7.2221","volume":"22","author":"M Mandegari","year":"2021","unstructured":"Mandegari M, Dastgheib SA, Asadian F, Shaker SH, Tabatabaie SM, Kargar S, et al. A meta-analysis for association of XRCC1, XRCC2 and XRCC3 polymorphisms with susceptibility to thyroid cancer. Asian Pac J Cancer Prev. 2021;22:2221\u201336.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2044_CR8","doi-asserted-by":"crossref","unstructured":"Liu W, Ma S, Liang L, Kou Z, Zhang H, Yang J. The association between XRCC3 rs1799794 polymorphism and cancer risk: a meta-analysis of 34 case\u2013control studies. BMC Med Genomics. 2021;14(1):117.","DOI":"10.1186\/s12920-021-00965-4"},{"key":"2044_CR9","doi-asserted-by":"crossref","unstructured":"Liu Q, Peng Q, Zhang B, Tan Y. X-ray cross-complementing family: the bridge linking DNA damage repair and cancer. J Transl Med 2023 211. 2023;21:1\u201314.","DOI":"10.1186\/s12967-023-04447-2"},{"key":"2044_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/sj.emboj.7600087","volume":"23","author":"T Yoshihara","year":"2004","unstructured":"Yoshihara T, Ishida M, Kinomura A, Katsura M, Tsuruga T, Tashiro S, et al. XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells. EMBO J. 2004;23:670\u201380.","journal-title":"EMBO J"},{"key":"2044_CR11","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/sj.ejhg.5201681","volume":"14","author":"S Han","year":"2006","unstructured":"Han S, Zhang HT, Wang Z, Xie Y, Tang R, Mao Y, et al. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Hum Genet. 2006;14:1136\u201344.","journal-title":"Eur J Hum Genet"},{"key":"2044_CR12","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.12659\/MSM.895165","volume":"21","author":"W Lu","year":"2015","unstructured":"Lu W, Wu G, Zhang B. Association between x-ray cross-complementing group 3 (XRCC3) thr241met polymorphism and risk of thyroid cancer: a meta-analysis. Med Sci Monit. 2015;21:3978\u201385.","journal-title":"Med Sci Monit"},{"key":"2044_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1097-2765(02)00595-6","volume":"10","author":"MA Brenneman","year":"2002","unstructured":"Brenneman MA, Wagener BM, Miller CA, Allen C, Nickoloff JA. XRCC3 controls the fidelity of homologous recombination: roles for XRCC3 in late stages of recombination. Mol Cell. 2002;10:387\u201395.","journal-title":"Mol Cell"},{"key":"2044_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.31557\/APJCP.2020.21.5.1197","volume":"21","author":"M Karimi-Zarchi","year":"2020","unstructured":"Karimi-Zarchi M, Abbasi H, Javaheri A, Hadadan A, Meibodi B, Tabatabaei RS, et al. Association of IL-12B rs3212227 and IL-6 rs1800795 polymorphisms with susceptibility to cervical cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2020;21:1197\u2013206.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"2044_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12029-020-00532-7","volume":"52","author":"Y Ghelmani","year":"2021","unstructured":"Ghelmani Y, Asadian F, Antikchi MH, Dastgheib SA, Shaker SH, Jafari-Nedooshan J, et al. Association between the hOGG1 1245C\u2009>\u2009G (rs1052133) polymorphism and susceptibility to colorectal cancer: a meta-analysis based on 7010 cases and 10,674 controls. J Gastrointest Cancer. 2021;52(2):389\u201398.","journal-title":"J Gastrointest Cancer"},{"key":"2044_CR16","doi-asserted-by":"publisher","first-page":"e1007309","DOI":"10.1371\/journal.pgen.1007309","volume":"14","author":"JH Sul","year":"2018","unstructured":"Sul JH, Martin LS, Eskin E. Population structure in genetic studies: confounding factors and mixed models. PLoS Genet. 2018;14:e1007309.","journal-title":"PLoS Genet"},{"key":"2044_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/ahg.12143","volume":"80","author":"YF Pei","year":"2015","unstructured":"Pei YF, Tian Q, Zhang L, Deng HW. Exploring the major sources and extent of heterogeneity in a genome-wide association meta-analysis. Ann Hum Genet. 2015;80:113.","journal-title":"Ann Hum Genet"},{"key":"2044_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5808\/GI.2012.10.2.117","volume":"10","author":"EP Hong","year":"2012","unstructured":"Hong EP, Park JW. Sample size and statistical power calculation in genetic association studies. Genomics Inform. 2012;10:117.","journal-title":"Genomics Inform"},{"key":"2044_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000477109","volume":"42","author":"R Sarwar","year":"2017","unstructured":"Sarwar R, Mahjabeen I, Bashir K, Saeed S, Kayani MA. Haplotype based analysis of XRCC3 gene polymorphisms in thyroid cancer. Cell Physiol Biochem. 2017;42:22\u201333.","journal-title":"Cell Physiol Biochem"},{"key":"2044_CR20","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1038\/s41467-021-26027-y","volume":"12","author":"M Mali\u010dki","year":"2021","unstructured":"Mali\u010dki M, Jeron\u010di\u0107 A, Aalbersberg IJ, Bouter L, ter Riet G. Systematic review and meta-analyses of studies analysing instructions to authors from 1987 to 2017. Nat Commun. 2021;12:5840.","journal-title":"Nat Commun"},{"key":"2044_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.14712\/18059694.2020.27","volume":"63","author":"F Asadian","year":"2020","unstructured":"Asadian F, Niktabar SM, Ghelmani Y, Kargar S, Akbarian E, Emarati SA, et al. Association of XPC polymorphisms with cutaneous malignant melanoma risk: evidence from a meta-analysis. Acta Medica (Hradec Kralove, Czech Republic). 2020;63:101\u201312.","journal-title":"Acta Medica (Hradec Kralove, Czech Republic)"},{"key":"2044_CR22","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/01.MLG.0000163765.88158.86","volume":"115","author":"EM Sturgis","year":"2005","unstructured":"Sturgis EM, Zhao C, Zheng R, Wei Q. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope. 2005;115:938\u201345.","journal-title":"Laryngoscope"},{"key":"2044_CR23","first-page":"147","volume":"33","author":"N HX","year":"2006","unstructured":"HX N, JC B, Q S, HW T, QX Z. Genetic polymorphisms of XRCC3 and susceptibility of papillary thyroid carcinoma | request PDF. Fudan Univ J Med Sci. 2006;33:147\u201352.","journal-title":"Fudan Univ J Med Sci"},{"key":"2044_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/BF03346438","volume":"31","author":"AK Siraj","year":"2008","unstructured":"Siraj AK, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O, et al. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in middle Eastern population. J Endocrinol Invest. 2008;31:893\u20139.","journal-title":"J Endocrinol Invest"},{"key":"2044_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1089\/thy.2009.0099","volume":"19","author":"HN Bastos","year":"2009","unstructured":"Bastos HN, Ant\u00e3o MR, Silva SN, Azevedo AP, Manita I, Teixeira V, et al. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid. 2009;19:1067\u201375.","journal-title":"Thyroid"},{"key":"2044_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1677\/ERC-08-0336","volume":"16","author":"NM Akulevich","year":"2009","unstructured":"Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009;16:491\u2013503.","journal-title":"Endocr Relat Cancer"},{"key":"2044_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mrfmmm.2011.03.003","volume":"709\u2013710","author":"WA Garc\u00eda-Quispes","year":"2011","unstructured":"Garc\u00eda-Quispes WA, P\u00e9rez-Machado G, Akdi A, Pastor S, Galofr\u00e9 P, Biarn\u00e9s F, et al. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res - Fundam Mol Mech Mutagen. 2011;709\u2013710:67\u201372.","journal-title":"Mutat Res - Fundam Mol Mech Mutagen"},{"key":"2044_CR28","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.7314\/APJCP.2013.14.11.6727","volume":"14","author":"S Fayaz","year":"2013","unstructured":"Fayaz S, Karimmirza M, Tanhaei S, Fathi M, Torbati PM, Fard-Esfahani P. Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population. Asian Pac J Cancer Prev. 2013;14:6727\u201331.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2044_CR29","first-page":"3160","volume":"8","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang K, Liu X, Liu B, Wang Z. Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer. Int J Clin Exp Pathol. 2015;8:3160\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"2044_CR30","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1159\/000443058","volume":"38","author":"L Yan","year":"2016","unstructured":"Yan L, Li Q, Li X, Ji H, Zhang L. Association studies between XRCC1, XRCC2, XRCC3 polymorphisms and differentiated thyroid carcinoma. Cell Physiol Biochem. 2016;38:1075\u201384.","journal-title":"Cell Physiol Biochem"},{"key":"2044_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s13277-015-3882-4","volume":"37","author":"K Yuan","year":"2016","unstructured":"Yuan K, Huo M, Sun Y, Wu H, Chen H, Wang Y, et al. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population. Tumor Biol. 2016;37:979\u201387.","journal-title":"Tumor Biol"},{"key":"2044_CR32","doi-asserted-by":"publisher","unstructured":"Gonzalez-Hormazabal P, Reyes JM, Blanco R, Bravo T, Carrera I, Peralta O, et al. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population. Mol Biol Rep. 2012;39:8091\u20138. https:\/\/doi.org\/10.1007\/s11033-012-1656-2.","DOI":"10.1007\/s11033-012-1656-2"},{"key":"2044_CR33","doi-asserted-by":"publisher","unstructured":"Santos LS, Gomes BC, Bastos HN, Gil OM, Azevedo AP, Ferreira TC, et al. Thyroid cancer: the quest for genetic susceptibility involving DNA repair genes. Genes (Basel). 2019;10(8):586. https:\/\/doi.org\/10.3390\/genes10080586.","DOI":"10.3390\/genes10080586"},{"key":"2044_CR34","doi-asserted-by":"publisher","unstructured":"Qin J, Fan J, Li G, Liu S, Liu Z, Wu Y. DNA double-strand break repair gene mutation and the risk of papillary thyroid microcarcinoma: a case\u2013control study. Cancer Cell Int. 2021;21(1):334. https:\/\/doi.org\/10.1186\/s12935-021-02032-5.","DOI":"10.1186\/s12935-021-02032-5"},{"key":"2044_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jconrel.2024.03.057","volume":"369","author":"Z Pan","year":"2024","unstructured":"Pan Z, Lu X, Hu X, Yu R, Che Y, Wang J, et al. Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters. J Control Release. 2024;369:517\u201330.","journal-title":"J Control Release"},{"key":"2044_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O\u2019Connor","year":"2015","unstructured":"O\u2019Connor MJ. Targeting the DNA damage response in cancer. Mol Cell. 2015;60:547\u201360.","journal-title":"Mol Cell"},{"key":"2044_CR37","first-page":"1","volume":"16","author":"Z Pan","year":"2025","unstructured":"Pan Z, Tan Z, Xu N, Yao Z, Zheng C, Shang J, et al. Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers. Nat Commun 2025 161. 2025;16:1\u201320.","journal-title":"Nat Commun 2025 161"},{"key":"2044_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.30699\/ijmm.18.3.148","volume":"18","author":"E Behboudi","year":"2024","unstructured":"Behboudi E, Charostad J, Nakhaie M, Khajouei A, Ghelmani Y. JNK signaling pathways and oncoviruses. Iran J Med Microbiol. 2024;18:148\u201362.","journal-title":"Iran J Med Microbiol"},{"key":"2044_CR39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1021\/acs.accounts.6b00506","volume":"50","author":"Y Chen","year":"2017","unstructured":"Chen Y, Xianyu Y, Jiang X. Surface modification of gold nanoparticles with small molecules for biochemical analysis. Acc Chem Res. 2017;50:310\u20139.","journal-title":"Acc Chem Res"},{"key":"2044_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-024-06995-9","volume":"7","author":"JH Kang","year":"2024","unstructured":"Kang JH, Lee Y, Kim DJ, Kim JW, Cheon MJ, Lee BC. Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers. Commun Biol. 2024;7:1\u201310.","journal-title":"Commun Biol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02044-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02044-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02044-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:43:15Z","timestamp":1760578995000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02044-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2044"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02044-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not involve any studies with human participants or animals conducted by the authors.Not applicable to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}